Name | Sotuletinib dihydrochloride |
---|
Description | Sotuletinib (BLZ945) dihydrochloride is an orally active and blood-brain barrier-permeable CSF1-R-specific inhibitor (IC50=1 nM). Sotuletinib (BLZ945) dihydrochloride induces tumor cell apoptosis and effectively inhibits tumor growth in mouse models. Sotuletinib dihydrochloride can be used in cancer and amyotrophic lateral sclerosis (ALS) research[1]. |
---|---|
Related Catalog | |
Target |
IC50: CSF1-R (1 nM)[1]. |
References |
Molecular Formula | C20H24Cl2N4O3S |
---|---|
Molecular Weight | 471.40 |